Your browser doesn't support javascript.
loading
Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
Bukowski, Alexandra; Hoyo, Cathrine; Hudgens, Michael G; Brewster, Wendy R; Valea, Fidel; Bentley, Rex C; Vidal, Adriana C; Maguire, Rachel L; Schmitt, John W; Murphy, Susan K; North, Kari E; Smith, Jennifer S.
Afiliação
  • Bukowski A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Hoyo C; Department of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina.
  • Hudgens MG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Brewster WR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Valea F; Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Bentley RC; Department of Obstetrics and Gynecology, Virginia Tech Carilion School of Medicine, Roanoke, Virginia.
  • Vidal AC; Department of Pathology, Duke University School of Medicine, Durham, North Carolina.
  • Maguire RL; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Schmitt JW; Department of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina.
  • Murphy SK; Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
  • North KE; Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
  • Smith JS; Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina.
Cancer Epidemiol Biomarkers Prev ; 31(8): 1564-1571, 2022 08 02.
Article em En | MEDLINE | ID: mdl-35654413
ABSTRACT

BACKGROUND:

High-risk human papillomavirus (hrHPV) testing is utilized in primary cervical cancer screening, generally along with cytology, to triage abnormalities to colposcopy. Most screening-based hrHPV testing involves pooled detection of any hrHPV or of HPV16/18. Cervical neoplasia progression risks based on extended hrHPV genotyping-particularly non-16/18 hrHPV types-are not well characterized. HPV genotype-specific incidence of high-grade cervical intraepithelial neoplasia or more severe (CIN2+) following an abnormal screening result was examined.

METHODS:

We assessed a US-based prospective, multiracial, clinical cohort of 343 colposcopy patients with normal histology (n = 226) or CIN1 (n = 117). Baseline cervical samples underwent HPV DNA genotyping, and participants were followed up to 5 years. Genotype-specific CIN2+ incidence rates (IR) were estimated with accelerated failure time models. Five-year CIN2+ risks were estimated nonparametrically for hierarchical hrHPV risk groups (HPV16; else HPV18/45; else HPV31/33/35/52/58; else HPV39/51/56/59/68).

RESULTS:

At enrollment, median participant age was 30.1 years; most (63%) were hrHPV-positive. Over follow-up, 24 participants progressed to CIN2+ (7.0%). CIN2+ IR among hrHPV-positive participants was 3.4/1,000 person-months. CIN2+ IRs were highest for HPV16 (8.3), HPV33 (7.8), and HPV58 (4.9). Five-year CIN2+ risk was higher for HPV16 (0.34) compared with HPV18/45 (0.12), HPV31/33/35/52/58 (0.12), and HPV39/51/56/59/68 (0.16) (P = 0.05).

CONCLUSIONS:

Non-16/18 hrHPV types are associated with differential CIN2+ progression rates. HPV16, 33, and 58 exhibited the highest rates over 5 years. HPV risk groups warrant further investigation in diverse US populations. IMPACT These novel data assessing extended HPV genotyping in a diverse clinical cohort can inform future directions to improve screening practices in the general population.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article